GB002, Inc., a wholly owned subsidiary of Gossamer Bio
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, GB002, Inc., a wholly owned subsidiary of Gossamer Bio sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
GB002, Inc., a wholly owned subsidiary of Gossamer Bio: 4 sponsored US clinical trials, none currently recruiting.
GB002, Inc., a wholly owned subsidiary of Gossamer Bio sponsors 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 3 completed. 0 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Pulmonary Arterial Hypertension, with 1 trials.
Upper-quartile sponsor footprint
GB002, Inc., a wholly owned subsidiary of Gossamer Bio sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
4 total, page 1 of 1
Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)
NCT04816604
GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)
NCT04456998
Clinical Study of Inhaled GB002 for Treatment of WHO Group I Pulmonary Arterial Hypertension
NCT03926793
Phase 1A Safety Trial of Inhaled PK10571 (GB002)
NCT03473236
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 2 |
Therapeutic Areas
How the GB002, Inc., a wholly owned subsidiary of Gossamer Bio early-phase archive is shaped
4 indexed studies, none listed as recruiting (0% open); 3 completed (75%).
Phase mix: 0 late (III/IV) vs 4 early (I/II) (early-phase heavy).
Top condition: Pulmonary Arterial Hypertension (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
GB002, Inc., a wholly owned subsidiary of Gossamer Bio: archived-pipeline peers nationwide
Peers matched on 4 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
GB002, Inc., a wholly owned subsidiary of Gossamer Bio sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 archived trials
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this GB002, Inc., a wholly owned subsidiary of Gossamer Bio page
4 registered trials is a research-attention snapshot, not an endorsement of GB002, Inc., a wholly owned subsidiary of Gossamer Bio or any single study.
- None of GB002, Inc., a wholly owned subsidiary of Gossamer Bio's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Pulmonary Arterial Hypertension is the condition GB002, Inc., a wholly owned subsidiary of Gossamer Bio studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Pulmonary Arterial Hypertension trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
GB002, Inc., a wholly owned subsidiary of Gossamer Bio pipeline card: 4 registered trials from official public datasets.Report a data error.